Introduction
============

The multi-resistant Gram-positive obligate anaerobe *Clostridioides (Clostridium) difficile* is the main nosocomial bacterial agent of antibiotic treatment associated diarrhea ([@B41]). The rise of *C. difficile* infection (CDI) coincides with the introduction of clindamycin, the first broad-band lincosamin against anaerobic Gram-negative pathogens ([@B8]; [@B58]). Currently, first line of treatment is the use of antibiotics like vancomycin, metronidazole and fidaxomicin. However, high recurrence rates, especially after treatment with vancomycin or metronidazole, make this disease difficult to manage ([@B61]; [@B41]).

A major factor influencing the course and outcome of CDI is the composition of the host intestinal microbiome and, connected to it, the bile acid status of the infected individual. Patients undergoing a CDI typically have an antibiotic dependent change of their microbiome followed by a transition from antibacterial to less antibacterial bile acids in their gastrointestinal tract ([@B87]). Most commonly, CDI manifests in form of pseudomembranous colitis, which is a strong inflammation of the large intestine. This is caused by massive tissue destruction and leukocytosis due to the production of two large glycosylating toxins, TcdA and TcdB. These exert their cytotoxic activity by inactivating small GTPases and disturbing the actin cytoskeleton dynamics leading to disruption of the gut epithelial barrier ([@B7]; [@B75]; [@B19]).

The production of TcdA and TcdB typically coincides with the entry of the bacteria into the stationary phase. Nevertheless, it is controlled by complex regulatory processes on multiple levels and by diverse environmental cues, including subinhibitory concentrations of antibiotics, temperature or the availability of carbon sources and amino acids ([@B26]; [@B15]). One central metabolite in this respect is [L]{.smallcaps}-cysteine that represses toxin production ([@B48]). Apart from that, [L]{.smallcaps}-cysteine also affects the expression of genes of amino acid biosynthesis, fermentation, energy metabolism, iron acquisition and stress response ([@B24]; [@B33]). Furthermore, there is a strong interconnectedness between iron and [L]{.smallcaps}-cysteine dependent gene regulation circuits. Several of the genes of the latter contain Fur boxes in their promoters, which are binding sites for the global iron-responsive transcriptional ferric uptake regulator (Fur) ([@B24]). If not metabolized effectively [L]{.smallcaps}-cysteine also has an inhibitory effect on growth on *C. difficile* as it was nicely shown in case of a mutant lacking the cysteine desulfidase CdsB ([@B34]).

Although there is strong correlation between CDI severity and the capability of the bacteria to produce TcdA and TcdB, this alone does not explain the virulence spectrum of *C. difficile* in its entirety. Accordingly, several other virulence factors such as extracellular proteases, surface layer proteins, a fibronectin binding protein (Fbp68), a collagen binding protein (CbpA), type IV pili and flagella have been shown or are suspected to contribute to disease severity and host colonization ([@B29]; [@B47]; [@B91]; [@B68]). Especially, the regulation of flagellation and its main structural component flagellin (FliC) is crucial for modulating adherence to host cells, promoting colonization and eliciting immune responses via toll-like receptor 5 ([@B84]; [@B23]; [@B9]). Moreover, flagellation and toxin production are co-regulated by an intricate genetic switch adding up to the complexity of toxin-related pathogenicity of *C. difficile* ([@B4]; [@B3]).

Currently, many single components and mechanisms of CDI that contribute to host colonization, disease outbreak and dissemination are known. However, their concerted action is still not fully understood. Bacterial PPIases (FKBPs, parvulins and cyclophilins) have in many instances been shown to modulate infectious processes ([@B89]). Among those are prominent representatives like Mip and Mip-like FKBPs, or parvulins, like SurA in Gram-negative as well as PrsA and PrsA2 in Gram-positive bacteria ([@B45]; [@B39]; [@B10]; [@B2]; [@B65]; [@B44]; [@B90]). Additionally, recent studies have shown the participation of cyclophilins in the maturation of a secreted nuclease in *Staphylococcus aureus* as well as in virulence traits, like biofilm formation in *Escherichia coli* or in sliding motility and amoeba infection by *Legionella pneumophila* ([@B80]; [@B93]; [@B73]). The aim of our study was to identify the interaction partners of the sole cyclophilin of *C. difficile* (CdPpiB) and to characterize its contribution to bacterial physiology as well as virulence. Our results show an unprecedented relationship between bacterial cysteine metabolism and CdPpiB with far reaching implications on virulence. Furthermore, a protein network controlling major cellular function including transcription, translation, protein folding, metabolism, and stress responses was uncovered.

Materials and Methods {#s1}
=====================

Bacterial Strains and Culture
-----------------------------

Bacterial strains and plasmids used in this study are listed in [Table 1](#T1){ref-type="table"}. *C. difficile* 630*Δerm* (hereafter referred to as wild type or wt) and its derivatives were cultured in BHIS medium (brain-heart infusion broth (Carl Roth GmbH, Germany) supplemented with 5 g/L yeast extract (BD Bacto^TM^, United States) and 1 g/L [L]{.smallcaps}-cysteine (Sigma-Aldrich^^®^^, Germany) or TY-medium (30 g/L tryptone, 20 g/L yeast extract) under anaerobic conditions (95% N~2~/5% H~2~). If necessary, 5 μg/mL erythromycin or 15 μg/mL thiamphenicol were added. *Escherichia coli* and *Bacillus megaterium* were cultured in LB medium supplemented with 100 μg/mL ampicillin, 10 μg/mL tetracycline or 30 μg/ml chloramphenicol at 37°C and 200 rpm. All antibiotics were purchased from Sigma-Aldrich^^®^^. Media were solidified by adding 1.5% (wt/vol) agar when needed.

###### 

Bacterial strains and plasmids used in this study.

  Name                                   Features                                                                                                                                                                                 References
  -------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------
  *C. difficile* str. 630Δ*erm*          Erythromycin-sensitive derivative of strain 630                                                                                                                                          DSMZ^†^ (DSM 28645) ([@B43])
  *C. difficile* str. 630Δ*erm*Δ*ppiB*   *cd03310::ClosTron*, Erm^R^                                                                                                                                                              This study
  *E. coli* DH10β                        Strain for cloning and plasmid propagation, F^−^ *mcrA Δ*(*mrr*-*hsdRMS*-*mcrBC*) Φ80d*lacZ*Δ*M15* Δ*lacX74 endA1 recA1 deo*R Δ(*ara*, *leu*)7697 *araD*139 *galU galK nupG rpsL* λ^−^   [@B32]
  *E*. *coli* CA434                      *E. coli* HB101 carrying the R702- conjugative plasmid (Tra^+^, Mob^+^)                                                                                                                  [@B71]
  *E. coli* BTH101                       F^−^, *cya*-99, *araD*139, *galE15*, *galK16*, *rpsL1* (Str^R^), *hsdR2*, *mcrA1*, *mcrB1*                                                                                               Euromedex, France
  *B. megaterium* MS941                  Strain for recombinant production, deficient of the major secreted protease, Δ*nrpM*                                                                                                     [@B94]
  pMTL82151                              Shuttle vector for complementation of *C. difficile* mutants; pBP1-*ori* (Gram-pos.), ColE1 *ori* (Gram-neg.), *tra*, MCS, Cm^R^                                                         [@B38]
  pPpiB_NStrep                           pMTL82151 carrying wild type *ppiB* including its 250 bp upstream and 50 bp downstream regions and a N-terminal StrepII-tag                                                              This study
  pDSW1728                               P~tet~::*mCherryOpt*, Cm^R^                                                                                                                                                              [@B72]
  pPpiB-tet                              *mCherryOpt* in pDSW1728 replaced by *cd03310* by SacI and BamHI yielding P*~tet~*::*ppiB*, Cm^R^                                                                                        This study
  pN-STREPXa1622                         Vector for recombinant protein production in *B. megaterium*, P*~xylA~*-StrepII-Xa-MCS, Tc^R^, Amp^R^                                                                                    [@B12]
  p119_PpiB                              pN-STREPXa1622 in which the ORF of *ppiB* (CD630_03310) was cloned using BglII and SphI                                                                                                  This study
  p119_CysK                              pN-STREPXa1622 in which the ORF of *cysK* (CD630_15940) was cloned using BglII and SphI                                                                                                  This study
  pKNT25                                 Low copy plasmid carrying the T25 subunit of adenylate cyclase with N-terminal MCS, Km^R^                                                                                                Euromedex, France
  pKNTB                                  pKNT25 carrying wt *ppiB*                                                                                                                                                                This study
  pUT18                                  High copy plasmid carrying the T18 subunit of adenylate cyclase with N-terminal MCS, Amp^R^                                                                                              Euromedex, France
  pUT18_CysK                             pUT18 carrying wt *cysK* of *C. difficile* str. 630Δ*erm*                                                                                                                                This study
  pUT18_Lrp                              pUT18 carrying wt *lrp* of *C. difficile* str. 630Δ*erm*                                                                                                                                 This study
  pUT18_FliC                             pUT18 carrying wt *fliC* of *C. difficile* str. 630Δ*erm*                                                                                                                                This study

†

Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH.

*In vivo* Cross-Linking for the Identification of PpiB Interaction Partners
---------------------------------------------------------------------------

Possible interaction partners of PpiB were identified by *in vivo* cross-linking as previously described ([@B13]). Briefly, *C. difficile* str. 630Δ*erm*Δ*ppiB* + PpiB-NStrep was grown for 8 h in 25 mL of BHIS and refreshed 1:1000 in 2 L BHIS. After 16 h 0.125 % (vol/vol) formaldehyde (AppliChem, Germany) was added for chemical cross-linking (30 min at 37°C). Excess formaldehyde was quenched for 5 min at 37°C by the addition of glycine at a final concentration of 130 mM. Cells were harvested and washed twice with PBS (4000 *g* for 20 min at 4°C). Finally, the cells were resuspended in 25 mL PBS supplemented with complete Protease Inhibitor Cocktail (Roche, Switzerland), and homogenized using FRENCH^^®^^ Press (Thermo, United States) or glass beads and FastPrep^^®^^ (MP Biomedicals, United States). Cell debris was removed by centrifugation (10,000 *g*, 10 min, 4°C), and filtering the supernatant through a 0.45 μm syringe filter. The supernatant was applied onto a 3 mL Strep-Tactin^^®^^ column (iba Lifesciences, Germany) in order to purify PpiB and its cross-linked partners according to manual instructions. The elution fraction was concentrated using Amicon Ultra-0.5 mL centrifugal filters (Merck, Germany) with a molecular cut-off of 10 kDa. For analysis, the concentrated eluate was mixed with 4x SDS loading buffer and subjected to decrosslinking by heating at 95°C for 30 min. Proteins were separated on a 12% acrylamide gel, and stained using Coomassie stain \[100 g/L (NH~4~)~2~SO~4~, 100 mL/L H~3~PO~4~, 20% vol/vol methanol\]. Bands of interest were analyzed by LC-MS as previously described ([@B14]). Resulting protein identifications (hits) were filtered according to their overall coverage by the LC/MS approach and the overall number of unique peptides. Hits with at least 15% coverage and two or more unique peptides were taken into account as this indicated robust enrichment. Ribosomal proteins were discarded because of their intrinsically high abundance in the cell and their known unspecific protein-protein interactions due to their overall strong basic character.

Bacterial Two Hybrid (BACTH) Screening
--------------------------------------

Protein-protein interactions were confirmed using the BACTH-system of Euromedex (France), which bases on an adenylate cyclase (CyaA) dependent reporter system. For this, *ppiB*, *fliC* (CD630_02390), *lrp* (CD630_35440) and *cysK* (CD630_15940) were cloned in frame with in two different vectors, each containing one subunit of the adenylate cyclase of *Bordetella pertussis* ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). After confirmation of correct cloning, the CyaA-deficient strain *E. coli* BTH101 was transformed with combinations of plasmids carrying *ppiB* and the respective interaction partners, and transformants were selected on LB-agar containing 50 μg/mL kanamycin and 100 μg/mL ampicillin. Single transformants were then streaked out on MacConkey-agar (BD Difco^TM^, United States) supplemented with 50 μg/mL kanamycin and 100 μg/mL ampicillin, incubated for 2 days at 30°C, and checked for pink coloring due to CyaA-activity.

Measuring the Interaction of PpiB and Lrp and Their Amino Acid Substitution Mutants by β-Galactosidase Assay
------------------------------------------------------------------------------------------------------------

*Escherichia coli* BTH101 carrying plasmid combinations that had been confirmed on MacConkey-agar were used in a β-galactosidase assay for quantitative comparison of interactions between amino acid mutants of PpiB and Lrp, respectively. For this, at least six clones of each transformation were picked and grown o/n (30°C, 200 rpm) in 5 mL LB medium supplemented with 50 μg/mL kanamycin, 100 μg/mL ampicillin and 0.5 mM IPTG (GERBU, Germany). Prior to the assay, bacterial growth was stalled by chilling the cultures for at least 30 min at 4°C and the OD~600~ was determined. Bacteria of 200 μL culture were pelleted (3500 rpm, 5 min, 4°C), and resuspended in 900 μL of Z-Buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, 10 mM KCl, 1 mM MgSO~4~, and freshly added 50 mM β-mercaptoethanol, pH 7.0). Bacteria were lysed by the addition of 50 μL chloroform and 50 μL 0.1% SDS (wt/vol) for 5 min at 30°C. After this, 200 μl of *o*-nitrophenyl-β-[D]{.smallcaps}-galactoside (ONPG, Roth GmbH, Germany) dissolved at 4 mg/mL in phosphate buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, pH 7.0) was added. The reactions were kept for 12 min at 30°C and subsequently stopped by the addition of 500 μL 1 M Na~2~CO~3~. After removal of cell debris and chloroform by centrifugation (14000 rpm, 5 min, 4°C) absorption at 420 and 550 nm were recorded with a VarioSkan^TM^ (Thermo Fisher, United States) plate reader. β-galactosidase activity, expressed in Miller Units, was calculated according to the following formula:
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Construction of a *ppiB* Destruction Mutant (Δ*ppiB*) in *C. difficile* 630Δ*erm* Using ClosTron
------------------------------------------------------------------------------------------------

A synthetic vector containing the region of *ppiB* (CD630_03310/CDIF630erm_00459) was designed with the help of the ClosTron website^[1](#fn01){ref-type="fn"}^ using the Perutka algorithm ([@B70]). *E*. *coli* CA434 was transformed with customized vectors for mating with *C. difficile* 630*Δerm* cells as described previously ([@B38], [@B36]). Mutants were selected on BHIS containing 15 μg/mL erythromycin and confirmed by PCR and sequencing using gene specific primers ([Table 2](#T2){ref-type="table"}).

###### 

Primers used in this study.

  Name                   Sequence^†^                                        Features                                 References
  ---------------------- -------------------------------------------------- ---------------------------------------- ------------
  PpiB_KompF1            gatg[agctt]{.ul}GAACCATTAATTGGGGATAATG             HindIII, for cloning into pMTL82151      This study
  PpiB_KompR1            atcat[gcggccgc]{.ul}TTTATCCTCATTTTTAAGTA ATATATA   NotI, for cloning into pMTL82151         This study
  PpiB_NStrep_F          cgggtggctccaTTCCATAATTTATTACCTTCCTTTTC             For introducing N-terminal SrepII-Tag    This study
  PpiB_NStrep_R          cagtttgaaaaaAATAAAAATCCTATAGTAACTATAGAAATG         For introducing N-terminal SrepII-Tag    This study
  PpiB_For4              TCTgagctcATGAAAAGGAAGGTAATAAATTATG                 SacI, for cloning into pDSW1728          This study
  PpiB_Rev4              ATAggatccTTAGTTTTTTTCTACATCTGAGTAA                 BamHI, for cloning into pDSW1728         This study
  CdPpiB_TH_For          gac[tctaga]{.ul}gGAAAATAAAAATCCTATAGTAAC           XbaI, for cloning into BACTH vectors     This study
  CdPpiB_TH_Rev          ctc[ggtacc]{.ul}gcGTTTTTTTCTACATCTGAGTAA           KpnI, for cloning into BACTH vectors     This study
  CdLrp_TH_For           gac[tctaga]{.ul}gGATGTTACAGATTACAGAATC             XbaI, for cloning into BACTH vectors     This study
  CdLrp_TH_Rev           ctc[ggtacc]{.ul}gcCAATATTGATTTTGCTTGTATTG          KpnI, for cloning into BACTH vectors     This study
  CdFliC_TH_For          gac[tctaga]{.ul}gAGAGTTAATACAAATGTAAGTG            XbaI, for cloning into BACTH vectors     This study
  CdFliC_TH_Rev          ctc[ggtacc]{.ul}gcTCCTAATAATTGTAAAACTCC            KpnI, for cloning into BACTH vectors     This study
  CdCysK_TH_For          gac[tctaga]{.ul}gTTATATAATAACGCATTAGAGTT           XbaI, for cloning into BACTH vectors     This study
  CdCysK_TH_Rev          ctc[ggtacc]{.ul}gcAAATATTCCCATAGACATATAC           KpnI, for cloning into BACTH vectors     This study
  Lrp_P32A_invF          GCAGTTTCAGAAAGAGTCAAAAG                                                                     This study
  Lrp_P32A_invR          tgcAGAAGTTAAACCAACTATTTTTCC                                                                 This study
  Lrp_P56A_invF          GATTCATTAGGCAGAGTTATAAAG                                                                    This study
  Lrp_P56A_invR          tgcGTTGACAATAGCTTTATATCCTTC                                                                 This study
  Lrp_P72A_invF          gcaAGCAATGGATATACAGAATTTATTG                                                                This study
  Lrp_P72A_invR          AAGAGAAATATGAATAAATGCCTTTAT                                                                 This study
  Lrp_P87A_invF          AGGATTGTAGAATGTCACCATAT                                                                     This study
  Lrp_P87A_invR          tgcGTCCTTTGCAGCTGACTC                                                                       This study
  Lrp_P135A_invF         gcaATACAAGCAAAATCAATATTGGC                                                                  This study
  Lrp_P135A_invR         CGTTGATAGTATAACAGAGG                                                                        This study
  PpiB_R50A_invF         GTAATACCAGGATTTATGATAC                                                                      This study
  PpiB_R50A_invR         tgcATGAAATATTATTCCATTGTAATATC                                                               This study
  PpiB_F109A_invF        gcaTTCATAATGCATAAAAACTCACCAC                                                                This study
  PpiB_F109A_invR        TTGAGAACCAGCTGAATTAGGTG                                                                     This study
  PpiB_F110A_invF        gcaATAATGCATAAAAACTCACCAC                                                                   This study
  PpiB_F110A_invR        AAATTGAGAACCAGCTGAATTAG                                                                     This study
  PpiB_For3              atg[agatct]{.ul}taATGGAAAATAAAAATCCTATAGTAAC       BglII, for cloning into pN-STREPXa1622   This study
  PpiB_Rev3              ta[gcatgc]{.ul}TTAGTTTTTTTCTACATCTGAGTAAT          SphI, for cloning into pN-STREPXa1622    This study
  CdCysK_119_F1          gcc[agatct]{.ul}TGTTATATAATAACGCATTAGAG            BglII, for cloning into pN-STREPXa1622   This study
  CdCysK_119_R1          ccg[gcatgc]{.ul}TTAAAATATTCCCATAGACATATAC          SphI, for cloning into pN-STREPXa1622    This study
  EBS universal primer   CGAAATTAGAAACTTGCGTTCAGTAAAC                                                                [@B37]
  ErmRAM_F               ACGCGTTATATTGATAAAAATAATAGTGGG                                                              [@B37]
  ErmRAM_F               ACGCGTGCGACTCATAGAATTATTTCCTCCCG                                                            [@B37]

†

Restriction recognition sites are underlined; bases for the respective alanine exchange are highlighted.

Assessing Growth and Susceptibility Toward Amoxicillin
------------------------------------------------------

Bacterial growth was monitored by refreshing cultures of *C. difficile* grown overnight (o/n) in 25 mL medium to a starting optical density (OD~600~ ~nm~) of 0.05 in 25 mL fresh medium. Increase in OD~600~ ~nm~ was measured starting with t~0~ and every 60 min until the cultures reached stationary phase. For assessing amoxicillin susceptibility, o/n cultures of wild type *C. difficile* and its Δ*ppiB* mutant were prepared in 20 mL BHIS medium. The next morning the cultures were adjusted to an OD~600~ ~nm~ of 0.1 in BHIS medium. Amoxicillin stock solution was prepared fresh (2 mM in ddH~2~O) and a 1:1 serial dilution starting at 256 μM was prepared in 100 μl of BHIS distributed in the wells of a 96-well plate. Following this, 100 μL of the bacterial suspension were added into each well resulting in a final OD of 0.05. Bacteria were grown for 6 h at 37°C under anaerobic conditions, and the final OD was measured at 600 nm using a VarioSkan^TM^ (Thermo Fisher, United States) plate reader.

Complementation of *C. difficile*Δ*ppiB* With StrepII-Tagged PpiB and Implementing a Tetracycline- Inducible Promoter
---------------------------------------------------------------------------------------------------------------------

In order to achieve a complementation of the mutant with wild type PpiB carrying a N-terminal StrepII-tag for affinity purification, *ppiB* was amplified including its 250 bp up- and 100 bp-downstream regions using the primer combination PpiB_KompF1/R1. This fragment was cloned into the shuttle vector pMTL82151 with *HindIII* and *BamHI* yielding pMTL_ppiB. This plasmid was used as a template for an inverse PCR by which an N-terminal StrepII-tag was added to PpiB with the primer combination PpiB_NStrep_F/R. The resulting PCR-product was gel purified, phosphorylated with T4 polynucleotide kinase (NEB) and re-ligated with T4 ligase (NEB) according to manufacturer's instructions. Plasmids carrying the desired mutations were selected in *E. coli* DH10β and verified by sequencing. For complementation of the Δ*ppiB* mutant under the control of a tetracycline-inducible promoter (P~tet~), the ORF of CdPpiB was cloned into pDSW1728 utilizing the restriction sites *SacI* and *BamHI*. The Δ*ppiB* mutant was transformed by conjugation and selected using 15 μg/ml thiamphenicol. For complementation studies the bacteria were cultured with 10 ng/mL anhydrotetracycline (AT), and a dose-dependent complementation was achieved by performing the assays with decreasing concentrations of TA starting at 400 ng/mL.

Recombinant Protein Production
------------------------------

For recombinant production, *ppiB* or *cysK* were amplified with Q5-Polymerase (NEB GmbH, Germany) and cloned into the production vector pN-STREPXa1622 using the restriction sites BglII and SphI yielding N-terminally StrepII-tagged proteins ([@B12]). For recombinant protein production, an o/n culture of transformed *B. megaterium* MS941 was prepared, and the next morning refreshed 1:100 in 300 ml LB medium containing 10 μg/mL tetracycline ([@B11]). The cells were induced at an OD~600~ ~nm~ of ∼0.4 by the addition of [D]{.smallcaps}-xylose (Carl Roth GmbH, Germany) at a final concentration of 0.5 % (w/v). After 6 h, the cells were harvested (3000 *g*, 15 min, 4°C), and the pellet was once washed with 1x PBS (5000 *g*, 15 min, 4°C). Cells were resuspended in 25 mL ddH~2~O, and disrupted by FRENCH^^®^^ Press (Thermo, United States). Immediately after the disruption, 10x wash buffer was added to a final concentration of 1x. Cell debris was removed by centrifugation (10000 *g*, 20 min, 4°C) and the supernatant was filtered through a 0.45 μm syringe filter. StrepII-tagged PpiB or CysK were purified from the supernatant using Strep-Tactin^^®^^ sepharose (iba Lifesciences, Germany) according to manufacturer's instructions. Concentration and buffer change of purified proteins were achieved by centrifugation (5000 *g*, RT) using Vivaspin^^®^^ 20 ultrafiltration units (Sartorius, Germany) with 30 or 10 kDa molecular weight cut offs. Proteins were stored in 100 mM HEPES (pH 7.0) at −20°C. Protein yield and purity were analyzed by SDS-page, and protein concentration was determined by absorption at 280 nm.

CysK Activity Assay
-------------------

Enzymatic activity of recombinantly produced CysK of *C. difficile* was measured photometrically as previously described with slight modifications ([@B83]; [@B76]). Briefly, the assays were performed in a 96-well format in 100 μL final volume. As substrates *O*-Acetyl-[L]{.smallcaps}-serine hydrochloride (OAS; Sigma-Aldrich^^®^^, A6262) and 5-Thio-2-nitrobenzoic acid (TNB) were used. 20 mM OAS stock solution was freshly prepared in 100 mM HEPES (pH 7.0). Fresh TNB-stock solution was prepared by dissolving 10 mM 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB; Sigma-Aldrich^^®^^, D8130) and 15 mM dithiothreitol in 100 mM HEPES (pH 7.0). Each reaction contained 2 mM OAS and 50 μM TNB. Following the addition of CysK at a final concentration of 7 μM, the reactions were monitored in a VarioSkan^TM^ (Thermo Fisher, United States) plate reader at 30°C by measuring the OD~412~ ~nm~ every 4 min. If needed CysK was denatured by incubating aliquots for 30 min at 56°C.

Determination of Toxin Concentration in Supernatants
----------------------------------------------------

For determining the toxin production, exponentially growing cultures were adjusted to an OD~600~ ~nm~ of 0.05 in 10 mL of fresh BHIS and grown at 37°C under anaerobic conditions. After 48 h, the culture supernatants of 2 mL of each culture were harvested (5000 *g*, 5 min, RT) and sterile filtered using 0.2 μm syringe filters. Toxin concentrations in culture supernatants were determined using the *Clostridium difficile* Toxin A OR B ELISA Kit (tgc-E002-1) of tgcBIOMICS (Germany) following the manual instructions.

Cytotoxicity Assay
------------------

In order to visualize the cytotoxic activity of *C. difficile* culture supernatants, NIH-3T3 mouse fibroblast cells (ATCC^^®^^ CRL-1658^TM^, United States) were cultured in DMEM (Gibco, United States) supplemented with 10% FBS at 37°C and 5% CO~2~. For the assay, 10^5^ cells/mL were seeded on glass cover slips in 24-well plates and cultured for 2 days. In parallel, *C. difficile* were grown in anaerobic chamber for 24 h, and the cell free supernatant containing secreted toxins was harvested by centrifugation (8000 *g*, 5 min, RT). This supernatant was diluted to 0.1 % (vol/vol) in cell culture medium. Adherent NIH-3T3 cells were washed once with 1 mL PBS, and 1 mL medium with bacterial culture supernatant was added. After incubation for 2 h, medium was removed and the cells were fixed for 15 min at RT with 2% (wt/vol) PFA in 1x PBS, and subsequently permeabilized with 0.1 % (vol/vol) Triton X-100 in 1x PBS with 1% (wt/vol) BSA for 5 min. Cells were stained with PBS containing 1 μg/mL DAPI (Sigma-Aldrich^^®^^) and 1:1000 diluted Phalloidin-Alexa488 (Abcam, United Kingdom). The mounted samples were analyzed with a confocal microscope (Leica^^®^^ SP8, Germany) using an 63x oil immersion objective.

Results
=======

Identification of the Protein Interaction Partners of CdPpiB
------------------------------------------------------------

A protein blast search using the PpiB sequence of *Bacillus subtilis* str. 168 (Uniprot ID: P35137) against the most recently annotated *C. difficile* str. 630Δ*erm* genome identified a single potential cyclophilin encoded by the gene locus CDIF630erm_00459 (CD630_00330 in *C. difficile* 630). This gene is flanked upstream by a gene potentially encoding for a patatin-like phospholipase, and downstream by a gene encoding the putative exosporium glycoprotein BclA1 ([@B20]). An alignment of the potential *C. difficile* cyclophilin with bacterial cyclophilins of *E. coli* str. K12 (EcPpiB; P23869), *B. subtilis* (BsPpiB; P35137) and *Staphylococcus aureus* str. NCTC8325 (SaPpiB; Q2FZU9) as well as eukaryotic representative members of yeast (ScCyp1; P14832) and human (HsCypA; P62937) revealed high amino acid sequence similarities between the different proteins. An exceptional high degree of conservation was observed for amino acid residues involved in PPIase activity ([Figure 1](#F1){ref-type="fig"}). Accordingly, this gene was selected for destruction by ClosTron, which resulted in the generation of a Δ*ppiB* mutant in the *C. difficile* str. 630Δ*erm* background.

![CdPpiB is a classical cyclophilin-type PPIase. The alignment of amino acid sequences of cyclophilin type PPIases of the Gram-positive species *S. aureus* (SaPpiB; Q2FZU9), *C. difficile* (CdPpiB; Q18D70) and *B. subtilis* (BsPpiB; P35137) as well as the Gram-negative model organism *E. coli* (EcPpiB; P23869), and the yeast (ScCyp1; P14832) and human CypA (HsCypA; P62937) reveals highly conserved amino acids along the PPIase active surface (marked by a black line). The alignment was performed using the T-Coffee webserver and visualized by Jalview 2.10.3b1. Amino acids that are conserved to 100% are highlighted by color coding according to Taylor ([@B85]; [@B63]; [@B92]). Amino acids that have been mutated in CdPpiB are marked by an asterisk.](fphar-10-00340-g001){#F1}

Next, we identified *in vivo* protein interaction partners of CdPpiB using an interactomics approach by using N-terminally StrepII-tagged PpiB as bait and formaldehyde as a cross-linker. A preparative SDS-PAGE of the purified protein complexes revealed in total, seven distinct protein bands that were cut out and prepared for LC-MS analysis ([Figure 2](#F2){ref-type="fig"}).

![*In vivo* cross-linking reveals putative interaction partners of CdPpiB. Shown is a representative analytical SDS-PAGE with the elution fraction after the *in vivo* cross-linking and the subsequent Strep-tag affinity purification of PpiB-StrepII and its putative interaction partners. Bands denoted with an asterisk were cut out analyzed by mass spectrometry. The bracket indicates bands that also occurred in control experiments without cross-linking and were excluded from the analysis.](fphar-10-00340-g002){#F2}

This yielded 39 unique hits, and as expected, PpiB was found to be with 83% the best covered protein among those. The majority of the remaining 38 hits that resembled proteins interacting either directly or indirectly in larger complexes with CdPpiB belonged to the functional groups metabolism (19 hits, 50%) and stress response (8 hits, 21%). The rest of the hits were distributed among transcription/translation, protein folding and transport (3 hits and 8% each) as well as motility/surface (2 hits 5%) ([Table 3](#T3){ref-type="table"}). Among the retrieved potential interaction partners were LdhA, AcdB, HadA, EtfA1, EtfA3, and EtfB1. These enzymes represent the complete pathway for phenylalanine and leucine fermentation ([@B52]). Similarly, the also detected pyruvate carboxylase Pyc, pyruvate-ferredoxin oxidoreductase Pfo, aldehyde-alcohol dehydrogenase AdhE2 and pyruvate kinase Pyk as well as the glyceraldehyde-3-phosphate GapA and fructose-1,6-bisphosphate aldolase Fba are central enzymes of carbon metabolism ([@B21]). Finally, the *O*-acetylserine sulfhydrylase/cysteine synthase (CysK), was among the metabolic proteins the one with the highest sequence coverage. It represents the last enzyme of cysteine biosynthesis ([@B24]).

###### 

Putative interaction partners of CdPpiB identified by *in vivo* cross-linking.

  Class                        Name                                         Accession-Nr.^†^   Gene locus^†^   Coverage (%)   \# unique peptides   Function
  ---------------------------- -------------------------------------------- ------------------ --------------- -------------- -------------------- ------------------------------------------------------------------------------
  Metabolism                   CysK                                         ARE62524.1         01767           40             13                   Cysteine synthase activity
                               GapA                                         ARE64122.1         03466           36             14                   Glyceraldehyde-3-phosphate dehydrogenase
                               Fba                                          ARE61306.1         00531           34             11                   Fructose-1,6-bisphosphate aldolase
                               Pyc                                          ARE60920.1         00083           32             40                   Pyruvate carboxylase
                               EtfA1                                        ARE61304.1         00529           28             10                   Isocaproyl-CoA dehydrogenase, electron transfer flavoprotein alpha subunit
                               AcdB                                         ARE61302.1         00527           24             8                    Isocaproyl-CoA dehydrogenase, catalytic subunit
                               PduL                                         ARE63606.1         02937           24             5                    Phosphate propanoyltransferase
                               Putative NUDIX-family hydrolase              ARE61693.1         00909           24             3                    Hydrolase
                               Pfo                                          ARE63605.1         02936           23             25                   Pyruvate synthase
                               NifU-like protein                            ARE62199.1         01433           23             3                    \[Fe--S\]-cluster assembly protein
                               AdhE2                                        ARE63909.1         03250           20             17                   Aldehyde-alcohol dehydrogenase
                               LdhA                                         ARE61297.1         00522           20             6                    [D]{.smallcaps}-lactate dehydrogenase
                               PfkA                                         ARE64384.1         03700           20             4                    ATP-dependent 6-phosphofructokinase
                               EtfA3                                        ARE61965.1         01196           19             6                    Electron transfer flavoprotein subunit alpha
                               Putative 5-nitroimidazole reductase          ARE62385.1         01623           19             3                    Putative 5-nitroimidazole antibiotic resistance protein
                               HadA                                         ARE61298.1         00523           18             6                    Isocaprenoyl-CoA:2-hydroxyisocaproate CoA-transferase
                               IorB                                         ARE63301.1         02620           18             3                    Indolepyruvate oxidoreductase, subunit beta
                               EtfB1                                        ARE61303.1         00528           17             4                    isocaproyl-CoA dehydrogenase, electron transfer flavoprotein beta subunit
                               Pyk                                          ARE64383.1         03699           16             7                    Pyuvate kinase
  Stress Response              Rbr1                                         ARE61727.1         00944           58             11                   Iron ion binding, oxidoreductase activity, rubrerythrin
                               Dsr                                          ARE61729.1         00946           36             4                    *In silico* predicted desulfoferrodoxin
                               Rbr2                                         ARE62400.1         01638           35             6                    Iron ion binding, oxidoreductase activity, rubrerythrin
                               Rbr3                                         ARE62452.1         01692           33             6                    *In silico* predicted reverse rubrerythrin
                               UspA                                         ARE61714.1         00930           22             3                    Putative universal stress protein A
                               YloU                                         ARE63487.1         02813           20             2                    Putative alkaline-shock protein
                               Alkaline shock protein (YqhY)                ARE62115.1         01349           17             2                    Alkaline shock protein
                               CspB                                         ARE62276.1         01511           15             2                    Cold shock protein
  Transcription/ Translation   Lrp                                          ARE64537.1         03859           30             4                    AsnC-family transcriptional regulator
                               InfC                                         ARE61586.1         00798           17             2                    Translation initiation factor IF-3
                               RFF                                          ARE63058.1         02368           16             2                    Ribosome-recycling factor
  Protein folding              Putative phage protein                       ARE61884.1         01109           29             5                    Protein-export protein, SecB-like
                               GroS                                         ARE61098.1         00314           23             2                    10 kDa chaperonin
                               DnaK                                         ARE63387.1         02707           22             13                   Chaperone protein, unfolded protein response
  Transport                    ABC transporter substrate- binding protein   ARE61772.1         00993           34             8                    ABC-type transport system, sugar-family extracellular solute-binding protein
                               Biotin carboxyl carrier protein              ARE62848.1         02143           23             5                    *In silico* predicted biotin carboxyl carrier protein
                               UPF0145 protein                              ARE62649.1         01899           23             2                    Putative heavy metal binding
  Motility/Surface             FliC                                         ARE61143.1         00361           54             19                   Flagellin
                               SlpA                                         ARE63719.1         03056           19             11                   S-layer precursor protein

†

as annotated in str. 630Δerm by

Dannheim et al. (2017a)

(GenBank: CP016318.1).

A whole battery of stress response proteins was also found attached to CdPpiB, including the two rubyerythrins Rbr1 and Rbr2 and the desulfoferrodoxin Dsr, which are involved in oxidative stress response ([@B50]; [@B74]). Furthermore, the cold shock protein CspB and the two alkaline shock proteins YloU and YqhY as well as the universal stress protein UspA were among the interacting proteins ([@B64]; [@B81]; [@B22]; [@B88]). The chaperones GroS and DnaK are part of multiple stress responses ([@B55]). Key players of translational quality control, the ribosome-recycling factor RRF, translation initiation factor IF-3 InfC and most interestingly, the pleiotropic transcriptional regulator Lrp were further proteins associated with CdPpiB ([@B16]; [@B67]; [@B56]). The screen also yielded flagellin (FliC, 54% coverage) and surface layer protein (SlpA, 19% coverage), two major virulence associated proteins ([@B84]; [@B59]). Finally, a sugar-family solute binding protein, a putative heavy metal binding protein (UPF0145) and a predicted biotin carrier protein were identified as transporter or transporter associated proteins cross-linked to CdPpiB ([Table 3](#T3){ref-type="table"}).

CdPpiB Interacts With Lrp, FliC and CysK in a Bacterial Two Hybrid System
-------------------------------------------------------------------------

In order to verify direct interactions between candidate proteins identified by our interactomic studies, we applied bacterial two hybrid (BACTH) based protein-protein interaction tests. For this, we chose Lrp as it is a global transcriptional regulator, and as there are no reports on functional interactions between bacterial PPIases and transcriptional regulators. Another candidate was the metabolic enzyme with the highest coverage, CysK, that participates in cysteine metabolism which is central to virulence of *C. difficile* ([@B24]). FliC was chosen as it is a well-established virulence factor in many pathogenic bacteria including *C. difficile* ([@B84]). For all the tested proteins a clear-cut interaction with CdPpiB was observed, indicated by pink coloring of the resulting clones on MacConkey-agar verifying our findings from the interactomics study ([Figure 3](#F3){ref-type="fig"}).

![Confirmation CdPpiB interaction partners with BACTH on MycKonkey-Agar. **(A)** *E. coli* BTH101 cells transformed with wt *ppiB* carrying pKNTB in combination with pUT18_FliC carrying wt *fliC* or pUT18_Lrp carrying wt *lrp* were streaked out on MacKonkey-agar and grown for 2 days at 30°C. **(B)** *E. coli* BTH101 cells transformed with wt *ppiB* carrying pKNTB in combination with pUT18_CysK carrying wt *cysK* were streaked out on MacKonkey-agar and grown for 2 days at 30°C. Purple coloring was indicative of protein interaction due to adenylate cyclase activity. On each plate *E. coli* BTH101 carrying empty pUT18 plasmid in combination with pKNTB served as negative control, whereas colonies carrying the pUT18-zip and pKT25-zip plasmids delivered by the manufacturer served as positive control. At least three colonies of each transformation were tested. Representative plates of three separate transformations are shown.](fphar-10-00340-g003){#F3}

An Intact PPIase Domain of CdPpiB Is Required for the Interaction With P87 Substrate of Lrp
-------------------------------------------------------------------------------------------

Following the confirmation of the interaction via the BACTH screen, we wanted to analyze whether these interactions may be dependent on the PPIase activity of CdPpiB. For this purpose, we chose Lrp for a detailed study as it is with 15 kDa comparably small and has only five proline residues. As PPIases act on the peptidyl-prolyl bonds in proteins, we exchanged all five proline residues in Lrp by alanine generating the single amino acid substitution mutants P32A, P56A, P72A, P87A and P135A. The interactions between CdPpiB and the generated Lrp-variants were quantified in β-galactosidase assays using the outlined BACTH system. Among the five Lrp-variants only variant P87A showed a significantly reduced β-galactosidase activity. It was with 868.8 ± 43.55 MU 30% less than the interaction with wild type Lrp which had an average β-galactosidase activity of 1246 ± 59.06 MU indicating a specific interaction between the two proteins ([Figure 4A](#F4){ref-type="fig"}). In order to prove that the PPIase domain is involved in the overall process, we went on by exchanging highly conserved single amino acid residues within the active site of CdPpiB that are known from homologous cyclophilins of Gram-positive and Gram-negative bacteria ([@B30]; [@B78]; [@B93]). Accordingly, we generated the CdPpiB variants R50A, F109A and F110A (s.a. [Figure 1](#F1){ref-type="fig"}). For all three mutants, significant differences were observed regarding the interaction with Lrp as assessed by β-galactosidase activity ([Figure 4B](#F4){ref-type="fig"}).

![CdPpiB targets P87 in CdLrp and this interaction depends on conserved amino acids. **(A)** β-galactosidase activities of *E. coli* BTH101 clones carrying combinations of wt CdPpiB and single proline exchange mutants of CdLrp. **(B)** β-galactosidase activities of *E. coli* BTH101 clones carrying combinations of wt CdLrp and single amino acid exchange mutants of CdPpiB. Clones carrying wt CdPpiB and the empty companion vector pKNT25 served as negative control in both experiments. Shown are mean and SEM of three independent experiments with at least five clones each. Statistical significance was calculated by unpaired *t*-Test with Welch's correction (^∗^*p* ≤ 0.05, ^∗∗^*p* ≤ 0.01, ^∗∗∗∗^*p* ≤ 0.0001, n.s., not significant).](fphar-10-00340-g004){#F4}

Destruction of *ppiB* Leads to Sensitivity to Envelope Stress and [L]{.smallcaps}-Cysteine in *C. difficile*
------------------------------------------------------------------------------------------------------------

As our interactomic data revealed that CdPpiB interacts with several stress response proteins, we performed a literature survey of available transcriptomic data. By this, we found that *ppiB* was the only PPIase of *C. difficile* that was significantly upregulated under cell wall stress caused by the beta-lactam amoxicillin ([@B27]). Accordingly, we tested the susceptibility of the Δ*ppiB* mutant in a serial dilution assay, and registered that the mutant was significantly more susceptible to amoxicillin concentrations ≥ 32 μM supporting our findings regarding the involvement of CdPpiB in stress tolerance ([Figure 5](#F5){ref-type="fig"}).

![CdPpiB-deficiency increases susceptibility toward amoxicillin. Wild type and its isogenic Δ*ppiB*-mutant were grown in the presence of decreasing concentrations of amoxicillin (Amx) and bacterial growth was measured at 600 nm. The graph depicts mean ± SEM of three separate experiments performed in duplicates. Statistical significance was calculated by unpaired *t*-Test (^∗^*p* ≤ 0.05, ^∗∗^*p* ≤ 0.01, n.s., not significant).](fphar-10-00340-g005){#F5}

We further went on characterizing the generated Δ*ppiB* mutant by performing growth assays using the standard rich medium BHIS, which is supplemented with 0.5% (wt/vol) yeast extract and 0.1% (wt/vol) [L]{.smallcaps}-cysteine. Here, the Δ*ppiB* mutant displayed a significantly delayed growth in BHIS medium containing [L]{.smallcaps}-cysteine. Slower growth in the exponential phase resulting in a later entry into stationary phase (9 h in wt vs. 12 h in Δ*ppiB*) was observed. The final OD after 22 h, were comparable for both strains ([Figure 6A](#F6){ref-type="fig"}). When the assays were repeated with plain BHI or with BHIS lacking [L]{.smallcaps}-cysteine, no difference between wild type and the Δ*ppiB* mutant were observed. These tests identified [L]{.smallcaps}-cysteine as the cause for the observed phenotype. In order to verify the *ppiB* mutation as sole cause for the observed differences, we complemented the mutant with an intact *ppiB* gene *in trans* and brought *ppiB* under the control of the tetracycline promoter (P~tet~) allowing fine-tuned expression under the control of anhydrotetracycline (aTc). The wild type strain and its isogenic Δ*ppiB* mutant were transformed, and grown in the presence of different concentrations of [L]{.smallcaps}-cysteine (2--62 mM) in combination of increasing concentrations of aTc (3,625-400 ng/mL) ([Figure 6B,C](#F6){ref-type="fig"}). When fully induced with 400 ng/mL, the Δ*ppiB* mutant was able to cope with 8 mM [L]{.smallcaps}-cysteine, which equals to the concentration in BHIS. Its growth under full induction was significantly better compared to reduced induction with 200 ng/mL or less aTc ([Figure 6B](#F6){ref-type="fig"}). Overexpressing *ppiB* in the wild type resulted in an even higher tolerance of up to 32 mM [L]{.smallcaps}-cysteine and a significantly better growth compared to lower induction levels. In case of 16 mM [L]{.smallcaps}-cysteine the wild type overexpressing *ppiB* reached optical densities comparable to the wild type gown at 8 mM [L]{.smallcaps}-cysteine without *ppiB* overexpression ([Figure 6C](#F6){ref-type="fig"}). These observations corroborated the interactomic data where CysK was the major metabolic protein interacting with CdPpiB.

![CdPpiB confers cysteine tolerance to *C. difficile*. **(A)** Destruction of *ppiB* causes growth defect in BHIS as assessed by the change in the OD~600~ ~nm~ over time. **(B)** Complementation of the Δ*ppiB* mutant through induction with 400 ng/mL anhydrotetracycline allows the bacteria to cope with 8 mM [L]{.smallcaps}-cysteine when grown in BHI supplemented with different concentrations of cysteine. **(C)** Stepwise over-expression of *ppiB* with increasing amounts of anhydrotetracycline raises the tolerance of the wild type toward 16 and 32 mM [L]{.smallcaps}-cysteine. Shown are means ± SEM of three independent experiments performed in duplicate. Statistical significance was calculated by unpaired *t*-Test (^∗^*p* ≤ 0.05, ^∗∗∗∗^*p* ≤ 0.0001).](fphar-10-00340-g006){#F6}

CdPpiB Restores CysK Activity After Heat Inactivation
-----------------------------------------------------

One important function of PPIases is the restoration of enzyme activity after protein inactivation by unfavorable chemical or physical conditions. In our interactomic study, we identified and verified CysK, the terminal enzyme in [L]{.smallcaps}-cysteine biosynthesis, as an interaction partner of CdPpiB. Accordingly, we tested the influence CdPpiB on heat inactivated CysK, the last enzyme of cysteine biosynthesis. Activity of recombinantly produced CysK was measured in a photometric assay at 412 nm, and was shown to be active at 7 μM concentration. Next, CysK was mildly heat denatured at 56°C for 30 min and its enzymatic activity was measured with or without five-fold excess of CdPpiB. As expected, heat denatured CysK showed no activity. But, the addition of 35 μM CdPpiB to the reaction efficiently restored its enzymatic activity ([Figure 7](#F7){ref-type="fig"}). This indicates that CdPpiB functionally interacts with CysK and promotes its structural stability.

![CdPpiB restores CysK-activity after heat denaturation. *O*-acetyl-sulfhydrylase activity of recombinant CysK was measured by the decrease of OD~412~ at 30°C. Activity of 7 μM recombinant CysK diminished after inactivation at 56°C for 30 min, and could be restored by the addition of recombinant PpiB in 5-times molar excess. Shown are mean and SEM of three independent measurements proteins of two different productions. Statistical significance was calculated by unpaired *t*-Test with Welch's correction (^∗^*p* ≤ 0.05, n.s., not significant).](fphar-10-00340-g007){#F7}

Deletion of *ppiB* Increases Toxin Production and Cytotoxic Activity
--------------------------------------------------------------------

Considering that CysK is a central enzyme in [L]{.smallcaps}-cysteine metabolism and that this amino acid is also a potent suppressor of toxin production, we tested the influence of CdPpiB on the cellular amounts of TcdA and TcdB under *in vitro* conditions ([@B48]; [@B24]). We quantified both toxins in stationary cultures of wild type and the *ppiB* mutant using ELISA. Both toxins were found in significantly higher concentrations in the culture supernatants of the *ppiB* mutant. While the wild type strain revealed in average 309 ng/mL TcdA in its culture supernatant, the *ppiB* mutant produced 2.8-fold more TcdA (868 ng/mL) ([Figure 8A](#F8){ref-type="fig"}). Similarly, TcdB was 2.3-fold higher concentrated in the growth supernatant of the mutant (89 ng/mL) compared to the wild type (40 ng/mL) ([Figure 8B](#F8){ref-type="fig"}). In accordance with the amounts of toxins found in the culture supernatant, the broth from mutant growth was considerably more active at 0.1% (vol/vol) dilution, causing stronger actin depolymerization and cell rounding of NIH-3T3 cells ([Figure 8C](#F8){ref-type="fig"}--[E](#F8){ref-type="fig"}). Similar results were obtained for the mutant complemented with the *ppiB* gene *in trans*, however, without gene induction by aTc ([Figure 8G](#F8){ref-type="fig"}). Wild type levels of toxins and corresponding cytotoxic effect similar to wild type were observed when the complemented mutant was induced with 400 ng/mL aTc ([Figure 8H](#F8){ref-type="fig"}). Cells treated with supernatants from wild type bacteria overexpressing *ppiB* exhibited no visual abnormalities of the cellular morphology ([Figure 8F](#F8){ref-type="fig"}). Hence, CdPpiB not only interacts with components of the [L]{.smallcaps}-cysteine metabolism and supports the growth in the presence of [L]{.smallcaps}-cysteine, but it also affects toxin production in *C. difficile*.

![Deletion of *ppiB* leads to higher toxin titres and cytotoxicity. **(A)** TcdA and **(B)** TcdB concentrations were measured by ELISA in 48 h old culture supernatants. Both toxins accumulated to significantly higher titres in culture supernatants in the isogenic Δ*ppiB* mutant. Shown are means ± SD of three independent experiments performed in duplicate. Statistical significance was calculated by unpaired *t*-Test (^∗^*p* ≤ 0.05). **(C--H)** PpiB influences the cytotoxic activity in the culture supernatant. **(C)** In untreated control NIH-3T3 cells the actin cytoskeleton is organized in stressfibers as it is typical for epithelial cells. **(D)** Cell-free supernatants from 24 h old wild type cultures that were diluted to 0.1% (vol/vol) in cell culture medium have visually no detrimental effect on the actin cytoskeleton. **(E)** Supernatants of the Δ*ppiB* mutant cause disintegration and rounding up of the cells at the same dilution. **(F)** Overexpression of *ppiB* by the addition of 400 ng/mL anhydrotetracycline (aTc) in a tetracycline-inducible system has no detrimental effect on the cells in the wild type background. **(G)** The complemented strain exerts comparable cytotoxic activity as the Δ*ppiB* mutant in the absence of aTc. **(H)** Overexpression of *ppiB* by the addition of aTc reduces the cytotoxic effect in the Δ*ppiB* background to wild type levels. Shown are representative views of two separate experiments performed in triplicates. Actin cytoskeleton was stained green with Alexa488-coupled phalloidin, while nuclear DNA was stained blue with DAPI. Scale bars correspond to 10 μm.](fphar-10-00340-g008){#F8}

Discussion
==========

The aim of this study was to gain insights into the physiological and virulence related functions of the cyclophilin CdPpiB of the nosocomial pathogen *C. difficile*. Our *in vivo* interactomics approach in combination with bacterial two hybrid testing allowed us the identification and verification of a specific set of interaction partners that are major control proteins of cell physiology and virulence. The majority of the interaction partners belonged to the category of energy and central metabolism ([Table 3](#T3){ref-type="table"}). Here, several functionally related proteins were identified, including LdhA, EtfA1, AcdB, EtfA3, HadA, and EtfB1. These enzymes are part of the same Stickland reaction involving [L]{.smallcaps}-leucine catabolism. By this, *C. difficile* harnesses metabolic energy from the oxidation of one equivalent of [L]{.smallcaps}-leucine to isovalerate, CO~2~ and NH~4~^+^. In return, two equivalents of [L]{.smallcaps}-leucine are reduced to isocapronate and NH~4~^+^ ([@B82]; [@B17]; [@B52]). This pathway is coupled via NAD^+^ and ferredoxin to the RNF complex responsible for proton/sodium gradient formation required for ATP generation in *C. difficile* ([@B53]; [@B1]).

Another group of proteins of putative interaction partners belonged to the primary carbon metabolism. These included pyruvate carboxylase Pyc, pyruvate-ferredoxin oxidoreductase Pfo, aldehyde-alcohol dehydrogenase AdhE2 and pyruvate kinase, which control the flux around the pyruvate knot of the central metabolism. On the other hand, the glyceraldehyde-3-phosphate GapA and fructose-1,6-bisphosphate aldolase represent key control points of glycolysis ([@B21]). Interestingly, *gapA* and *adhE2* were also up-regulated under cysteine rich conditions ([@B24]; [@B33]). Thus, CdPpiB potentially controls the major fluxes of the central metabolism of *C. difficile*.

The second largest group of interaction partners belonged to the group of stress response, including proteins protecting against temperature, oxidative and alkaline shock. In line with this, the Δ*ppiB* mutant was more susceptible to amoxicillin, which causes cell wall stress. This finding was also in accordance with a previous microarray study, where *ppiB* was significantly upregulated in amoxicillin treated *C. difficile* ([@B27]). Currently, we do not know how CdPpiB may influence this phenotype. However, the well-known chaperones DnaK and GroS as well as YloU and YqhY were also upregulated in case of amoxicillin stress ([@B27]). In *S. aureus* DnaK is part of the cell wall stress stimulon, and *dnaK* mutants have a higher susceptibility toward the beta-lactam oxacillin ([@B69]; [@B77]). Recently, DnaK was identified as a binding partner of EcPpiB in functional complementation and co-precipitation studies in *E. coli*, where it positively influenced the enzymatic activity and correct localization of DnaK ([@B80]). Hence, it is conceivable that, also in *C. difficile*, CdPpiB is part of the DnaK stress response network. This feature might further be supported by the interactions with YloU and YqhY, which are close homologs of the alkaline shock protein 23 (Asp23) of *S. aureus* that is also associated with cell envelope stress ([@B62]; [@B88]). EcPpiB is connected to another cell envelope related phenomenon, namely, cell division by directly interacting with FtsZ and probably further client proteins ([@B79]). Our interactomic study did not identify FtsZ as interaction partner in *C. difficile*. This might indicate that cyclophilins perform species-specific duties despite their high degree of conservation.

Several oxidative stress response proteins of the group of (Rbr1, Rbr2, and Rbr3) and a desulfoferrodoxin (Dsr) were found to bind to CdPpiB. Rubrerythrins are small proteins that have NADH-dependent peroxidase activity and act in concert with rubredoxins and desulfoferrodoxins ([@B60]). The homologs of Rbr1 and Dsr are important for conferring O~2~-tolerance to *C. acetbutylicum* under the control of the transcriptional regulator PerR, which located between these two genes in *C. difficile* ([@B40]; [@B50]; [@B20]). As these proteins act in close vicinity for efficient electron transfer, it is likely that CdPpiB is involved in complex formation or stability supporting their physiological function. Moreover, oxidative stress genes are upregulated in the presence of [L]{.smallcaps}-cysteine in *C. difficile* ([@B24]; [@B33]).

Two well-established virulence partners, namely the flagellar subunit FliC and the surface layer protein SlpA, were among the CdPpiB interaction partners. In case of FliC this interaction was confirmed by BACTH indicating a functional relationship between these proteins. Two oligomeric states of FliC seem to co-exist: the monomer which has been found in diverse cellular compartments and the polymeric organelle which is employed for motility, attachment and penetration ([@B18]). In fact, the implications of FliC monomers in invasiveness and virulence to the host are not restrained to *C. difficile* but apply to many other bacteria. For instance, in *Pseudomonas aeruginosa* or *Salmonella typhimurium* FliC appears to be the most prominent virulence factor in terms of inflammasome and immune response activation ([@B25]; [@B28]). Interestingly, FliC was shown to interact with DnaK in the periplasm of *P. aeruginosa*, and in *C. difficile* a Δ*dnaK* mutant had four-fold diminished *fliC* and four-fold increased *groS* expression ([@B14]; [@B46]). This supports our idea of CdPpiB being a crucial part of the chaperone network of *C. difficile*.

Next to some transport related proteins, very crucial factors of translational fidelity, IF-3 and RRF, were detected by interactomics. IF-3 is involved in the stabilization of the 30S ribosomal subunit, enabling mRNA binding to the 30S subunit and warranting the accuracy of the first aminoacyl-tRNA binding ([@B42]). The RRF, on the other hand, facilitates the dissociation of ribosomes from mRNA after termination of translation. RRF was together with elongation factor P one of the two highly upregulated translation factors in *B. subtilis* ([@B67]). As a foldase CdPpiB might, indeed, be in close vicinity of ribosomes and assist folding of newly synthesized proteins. However, there are currently no reports supporting this. Also, there is with trigger factor a known ribosome associated protein with a FKBP-domain that was shown to accompany proteins during their maturation following translation ([@B31]; [@B49]). This ubiquitous protein is also present in *C. difficile* (CDIF630erm_03607/CD630_33060) and is accordingly expected to be the major PPIase that facilitates protein folding. Nevertheless, it could be that CdPpiB does not associate with newly synthesized proteins but is involved in the recycling of translation factors for efficient ribosomal fidelity.

One of the most interesting binding partners was the transcriptional regulator Lrp. Hence, we analyzed the putative interaction between CdPpiB and Lrp in more detail and showed that this interaction depends on the PPIase active site residues. Mutating the highly conserved R50 and F109 weakened, while a F110A substitution significantly strengthened the association between both proteins. In return, out of the five proline residues of CdLrp only mutating P87 reduced the interaction of both proteins indicating a specific PPIase client protein relationship. Lrp-type proteins are global transcriptional regulators that consist of a classical N-terminal helix-turn-helix DNA-binding domain and a C-terminal substrate binding/ activation domain and typically act as specific regulators of amino acid metabolism-related genes ([@B16]). However, in *B. subtilis* LrpC, a close homolog of CdLrp, was also shown to be important for DNA-repair ([@B57]). More interestingly, deleting *decR* (STM0459), a very close homolog of CdLrp in S*almonella typhimurium*, rendered the bacteria more susceptible to [L]{.smallcaps}-cysteine ([@B66]). Hence, the cysteine-dependent phenotypes of the Δ*ppiB* mutant might be due to the participation of CdPpiB on multiple levels ranging from gene regulation to enzymatic activity. The proline residue at position 87 is in the vicinity of the substrate binding/activation domain. Considering that peptidyl-prolyl-*cis/trans*-isomerization results in conformational changes in proteins, it is possible that CdPpiB assists CdLrp in changing its conformation upon binding its substrate or that it regulates the conformational equilibrium of CdLrp for a fine-tuned gene expression. Currently, only for eukaryotic PPIases examples of gene regulatory actions in the form of transcription complex stabilization or mRNA maturation are known ([@B35]; [@B86]). To the best of our knowledge, this is the first time a direct interaction between a PPIase and a transcriptional regulator with direct implications on gene regulation has been shown in bacteria.

Interestingly and also in accordance with the interactomic findings, the Δ*ppiB* mutant showed two [L]{.smallcaps}-cysteine dependent phenotypes: a higher susceptibility toward [L]{.smallcaps}-cysteine and accumulation of more toxin in the supernatant. Typically added to the medium to promote growth, [L]{.smallcaps}-cysteine has also some detrimental effects because of the generated H~2~S during its degradation. As a result, deleting cysteine catabolizing genes results in decreased cysteine tolerance in bacteria ([@B66]; [@B34]). Cysteine is also among several metabolic stimuli that inhibit toxin production in *C. difficile* on transcriptional level, and it does so via its degradation byproducts pyruvate and H~2~S ([@B48]; [@B24]). That cysteine tolerance and regulation of toxin expression converges via the cysteine metabolism was recently shown in a mutant lacking the cysteine desulfhydrase CdsB. This mutant was impaired in its growth in the presence of 5 mM [L]{.smallcaps}-cysteine and its toxin production was unaffected by [L]{.smallcaps}-cysteine ([@B34]). These observations overlap with the Δ*ppiB* mutant in our study, and are further supported by the identification of CysK as an interaction partner of CdPpiB. As a *O*-acetylserine sulfhydrylase CysK catalyzes the synthesis of [L]{.smallcaps}-cysteine from *O*-acetyl-[L]{.smallcaps}-serine and sulfide ([@B54]). But it was also speculated that at higher [L]{.smallcaps}-cysteine concentrations CysK catalyzes the opposite reaction and contributes to [L]{.smallcaps}-cysteine degradation by desulfhydration ([@B5]; [@B6]; [@B24]). This was further supported by the observation that in *C. difficile* CysK was together with CysE one of the two transcriptionally most up-regulated genes of the cysteine metabolism in [L]{.smallcaps}-cysteine treated *C. difficile* ([@B24]; [@B33]). In our study, we showed that CdPpiB interacts with CysK and it restores the enzymatic activity of denatured CysK. Considering this and the similarities between the phenotypes, we propose that CdPpiB contributes to [L]{.smallcaps}-cysteine tolerance of *C. difficile* by stabilizing the metabolic network on the enzymatic level. Here again, a cooperative action with other chaperones cannot be excluded as *dnaK* and *groS* were also among the highly up-regulated genes in the presence of [L]{.smallcaps}-cysteine ([@B24]). Furthermore, a direct or indirect influence on the transcription of toxin genes by CdPpiB cannot be excluded and would need further analysis.

Taken together, CdPpiB is a key regulator that acts at the protein folding and modification level and controls central cellular processes. We also suggest that targeting CdPpiB as a therapeutic strategy aiming at virulence reduction may prove intricate, since in the absence of PpiB the bacteria become more toxigenic. Our findings confirm the contribution of the PPIase domain to its regulatory activity. But recent findings also suggest that cyclophilin function in bacteria does not solely rely on PPIase activity ([@B79]; [@B51]). Accordingly, whether the PPIase-activity itself or some domains other than the PPIase domain are crucial for a certain interaction or even biological function still need to be evaluated in the future.
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